CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 95,005 Value ($000) $2,062 Avg Close $23.61 Range $20.40 - $26.58
Q1 2025
Shares 161,272 Value ($000) $3,911 Avg Close $22.52 Range $19.15 - $26.16
Q3 2024
Shares 10,057 Value ($000) $200 Avg Close $18.54 Range $14.97 - $21.67
Q1 2023
Shares 192,926 Value ($000) $3,199 Avg Close $16.50 Range $13.30 - $22.11
Q4 2022
Shares 29,866 Value ($000) $556 Avg Close $15.40 Range $12.08 - $19.78
Q3 2022
Shares 103,008 Value ($000) $1,322 Avg Close $11.85 Range $6.87 - $17.22
Q1 2022
Shares 24,431 Value ($000) $203 Avg Close $7.07 Range $5.24 - $8.64
Q4 2021
Shares 36,271 Value ($000) $246 Avg Close $6.58 Range $5.05 - $7.58
Q1 2020
Shares 49,050 Value ($000) $189 Avg Close $4.10 Range $2.55 - $5.28
Q2 2019
Shares 14,332 Value ($000) $55 Avg Close $4.32 Range $2.23 - $6.16
Q4 2018
Shares 36,700 Value ($000) $70 Avg Close $2.86 Range $1.85 - $3.89
Q3 2018
Shares 31,012 Value ($000) $117 Avg Close $3.13 Range $2.70 - $4.05
Q2 2018
Shares 25,000 Value ($000) $78 Avg Close $3.03 Range $2.18 - $3.98